AURA — AURA BIOSCIENCES Balance Sheet
0.000.00%
Last trade - 00:00- $309.15m
- $158.06m
- 39
- 21
- 50
- 29
Annual balance sheet for AURA BIOSCIENCES, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 17.4 | 149 | 189 | 226 | 151 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 18.5 | 154 | 197 | 232 | 161 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3.57 | 6.2 | 26 | 22 | 20.6 |
| Other Long Term Assets | |||||
| Total Assets | 22.1 | 160 | 224 | 255 | 183 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.66 | 7.36 | 10.5 | 12.4 | 14.9 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.74 | 7.71 | 28.4 | 29.2 | 30.5 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 19.4 | 152 | 196 | 226 | 152 |
| Total Liabilities & Shareholders' Equity | 22.1 | 160 | 224 | 255 | 183 |
| Total Common Shares Outstanding |